Dr. Derek Cheng, MD

Dr. Cheng practices at Cedars-Sinai Medical Care Foundation in Beverly Hills, California.

Dr. Cheng's NPI, 1093928160, was assigned on May 7, 2007. Dr. Cheng graduated from Tufts University School Of Medicine in 2005. Dr. Cheng holds California license A97907.

Dr. Cheng's primary practice is Cedars-Sinai Medical Care Foundation, at 8536 Wilshire Blvd, Beverly Hills, CA 90211 in Los Angeles County. The practice phone is (310) 385-3200.

Dr. Cheng's primary practice is Cedars-Sinai Medical Care Foundation in Beverly Hills, California. Dr. Cheng is also affiliated with Cedars-Sinai Medical Center. The medical group on file is Cedars-Sinai Medical Group.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cheng practices. Vendor and product names are available with a free account.

Gastroenterology is Dr. Cheng's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Cheng is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Cheng is licensed in California.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, gastroduodenitis, gastroenteritis and gastrointestinal bleeding among the conditions Dr. Cheng treats.

CMS data shows 666 Medicare services from Dr. Cheng across 13 procedure codes in 2024, for 322 Medicare patients. Medicare paid $61,297 for them.

CMS counts 322 Medicare patients who saw Dr. Cheng in 2024. The largest group is 65 to 74, with 171 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 23% are also on Medicaid. Their average risk score is 1.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cheng's median patient age at 51, with 63% women.

In 2024, Dr. Cheng wrote 593 Medicare Part D claims for 166 patients. 87% of them were for generic drugs. CMS names the drug for 430 of them, across 14 drugs with 11 or more claims each, at $40,792 in total drug cost. In 2023, CMS named 423 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Cheng for performance year 2024, reported as part of a group. Dr. Cheng accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cheng as offering telehealth. CMS counts 70 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Cheng, more than 69% of the clinicians it reports for that procedure.

CMS Open Payments shows 67 general payments to Dr. Cheng from 11 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 87% of the total. Abbvie Inc. paid the most, $975.

Dmand AI lists 1 award for Dr. Cheng, most recently CMS Stage 1 EHR in 2013.

Dr. Cheng graduated from Tufts University School Of Medicine in 2005.

Dr. Cheng is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.